Despite increasing migration, the impact of HIV epidemics from Central and Eastern Europe (C&EE) on the UK HIV epidemic remains small. C&EE-born adults comprised 1 . 2 % of adults newly diagnosed with HIV in the UK between 2000 and 2007. Most C&EE-born women probably acquired their infection heterosexually in C&EE. In contrast, 59 % of C&EE-born men reported sex with men, half of whom probably acquired their infection in the UK. Previously undiagnosed HIV prevalence in C&EE-born sexual-health-clinic attendees was low (2007, 0 . 5%) as was overall HIV prevalence in C&EE-born women giving birth in England (2007, <0 . 1%). The high proportion of men who have sex with men (MSM) suggests under-reporting of this group in C&EE HIV statistics and/or migration of MSM to the UK. In addition to reducing HIV transmission in injecting drug users, preventative efforts aimed at C&EE-born MSM both within their country of origin and the UK are required.
INTRODUCTION
In the UK over the past 5 years, the annual number of new HIV diagnoses has stabilized at a high level [1, 2] . In many other European countries, new HIV diagnoses continue to rise [3, 4] . In 2007, the highest rate across the three World Health Organisation (WHO) European subregions [3] (see Appendix for subregions) was observed in the East (165 per million population), followed by the West (77 per million) and Centre (10 per million) [4] . In Eastern Europe (EE), injecting drug use (IDU) is the main transmission route although infections acquired heterosexually, mostly in sexual partners of IDU populations, have also risen [3, 4] . Prevalence estimates of HIV in Georgia, Belarus, Ukraine, Latvia and Estonia in injecting drug users exceed 10% [3] . In Central Europe (CE), HIV prevalence remains low and stable with an increasing number of HIV cases acquired through sexual transmission [4] .
There is evidence that population movement facilitates the spread of HIV [5] [6] [7] [8] [9] . In 2007, an estimated 831 026 Central and Eastern Europe (C&EE)-born adults were living in England, Wales and Northern Ireland (E,W&NI) whereas, in 2000 the figure was 303 957 [10] . Two thirds of C&EE migrants in 2007 (65 %, 539 017/831 026) were from the eight accession countries (A8) that joined the EU in 2004 (Poland, Czech Republic, Slovakia, Hungary, Slovenia, Estonia, Latvia, Lithuania) [10] [11] [12] . This recent rise in migration to the UK has generated some concern and media speculation of potential adverse health and economic impact [13] [14] [15] [16] [17] . In this study, we assess the impact of HIV epidemics in C&EE on the HIV epidemic in the UK.
METHODS
We analysed HIV data in adults (o15 years) in E,W&NI (data for Scotland was omitted as country of birth was not available) from three HIV surveillance systems held at the Health Protection Agency, Centre for Infections, including : (1) new HIV diagnoses, which collects detailed demographic, epidemiological information and CD4 count at diagnosis ; (2) unlinked anonymous genitourinary medicine (GUM) clinic survey, which measures the prevalence of previously undiagnosed HIV by using residual serum leftover syphilis blood samples from individuals attending 15 sentinel GUM clinics ; (3) unlinked anonymous HIV seroprevalence survey of neonatal dried blood spots (conducted in England only), which measures overall HIV prevalence in woman giving birth [2] . Data are reported for the period 2000-2007 or 2007 alone.
The WHO European subregion definitions for CE and EE were used [3] . To calculate rates of new HIV diagnoses, migration data from the quarterly household-based Labour Force Survey (July-September 2000-2007) were used [10] . Population estimates of people living in E,W&NI were obtained from the Office for National Statistics [18] . Proportions were calculated among all individuals for whom the relevant information was available. Numbers may rise as further reports are received, particularly for recent years. slightly higher for men than women (30 vs. 26 years respectively). Sixty-one per cent (220/362) of C&EE-born adults probably acquired their infection in C&EE (212 in their country of birth), of whom half (110/218) were infected heterosexually, a quarter (56/ 218) through SBM and one-fifth (48/218) through IDU (Table 1) . One hundred and twelve (31 %) C&EE-born adults probably acquired their HIV infection in the UK over the period. Of the men, 86 % (65/76) were probably infected through SBM and all with the exception of one of the women (35/36) through heterosexual contact (Table 1) . In UK-born adults, only 0 . 2% (15/8522) probably acquired their HIV infection in C&EE over the 8-year period.
RESULTS

New HIV diagnoses
Of C&EE-born adults diagnosed in 2000-2007 and who were probably infected heterosexually in the UK, 78 % (31/40) reported a partner infected in subSaharan Africa. In UK-born adults probably infected heterosexually in the UK, 0 . 5% (6/1205) reported a sexual partner infected in C&EE, 24 % (295) a partner infected in the UK and 44 % (530) a partner infected in sub-Saharan Africa.
CD4 count at diagnosis is an important determinant of HIV-related morbidity and mortality in the UK. Of the 404 C&EE-born adults, 72 % (292) had a CD4 count at diagnosis, of whom 25 % (74/292) were diagnosed with a CD4 count <200 cells/mm 3 (within 3 months of diagnosis), at a point after which therapy should have begun. This proportion was similar to UK-born adults diagnosed in 2000-2007 (26 %, 2144/ 8283) and lower than sub-Saharan African-born adults (38 %, 5305/13 798). in the UK. The rate of new HIV diagnoses in C&EE-born adults was lower than the overall rate of HIV diagnoses in adults in E,W&NI. The prevalence of HIV in GUM clinic attendees and pregnant women remains very low in this group. Late presentation (CD4 count <200 cells/mm 3 within 3 months of diagnosis) of HIV remains a concern in C&EE-born adults newly diagnosed in the UK. Individuals diagnosed late are at greater risk of early death [19, 20] .
Undiagnosed HIV infection in GUM attendees
Several factors help explain the limited impact of the C&EE HIV epidemics on the UK. First, migration data indicate that most C&EE migrants to the UK in recent years have been predominately from low HIV prevalence areas (Poland, Slovakia, Lithuania) [10, 21] , where some prevalence rates of HIV are lower than in the UK [4] . Second, HIV epidemics in many C&EE countries are driven by a very high prevalence in injecting drug users [3, 4] , and there is evidence that these individuals may have less opportunities or motivation to migrate to other countries given often difficult socioeconomic, legal and medical circumstance [9, [22] [23] [24] . Furthermore, better access to free needleexchange services in the UK [23, 25, 26] may have reduced the likelihood of C&EE-born individuals becoming infected through IDU after their arrival. Offering voluntary and confidential HIV testing to injecting drug users and scaling up measures to reduce onward transmission in this group and their sexual partners remains a priority in C&EE countries [3] .
Stigma, discrimination and the lack of confidentiality (in some countries) are also major barriers to HIV testing and access to care in men who have sex with men (MSM) [27] [28] [29] [30] . MSM were overrepresented (58 %) in C&EE-born men diagnosed in the UK. This is in contrast to national HIV figures from CE and EE countries where MSM accounted for 17 % and 0 . 5 %, respectively, of new diagnoses in men in recent years [31] . Our findings are likely to reflect under-reporting of MSM in these countries and/or selective migration of MSM to the UK as a result of stigma and discrimination.
The results show a small number of UK-born individuals having acquired their infection in C&EE. This highlights the ongoing need for awareness of safer sex in travellers to high-prevalence areas.
The study has several limitations. Data for Scotland had to be omitted as country of birth is not available. Probable route of infection and place of infection were missing for a quarter of new diagnoses and CD4 count for a third of cases. However, there is no evidence to suggest a bias in data collection or follow-up. Misreported or missing information may also influence prevalence estimates based on unlinked anonymous surveillance. Previously undiagnosed HIV infection reported in GUM clinic attendees is likely to be higher than the general population as these individuals are known to have substantially higher risk than the general population [2] . Rates of diagnoses rely on migration estimates from the Labour Force Survey which are subject to both sampling and non-sampling errors [32] .
CONCLUSION
National HIV surveillance systems indicate little impact of the C&EE HIV epidemics on the UK epidemic. C&EE-born adults accounted for only 1 . 2% of newly diagnosed adults in E,W&NI for 2000-2007 and the HIV prevalence in GUM clinic attendees and pregnant woman born in C&EE is very low. In addition to targeted interventions for IDU, HIV prevention efforts should particularly focus on C&EE-born MSM, both in their country of origin and within the UK.
APPENDIX. WHO European subregions
The West (23 countries) : Andorra, Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, United Kingdom. The Centre (15 countries) : Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Hungary, the Former Yugoslav Republic of Macedonia, Montenegro, Poland, Romania, Serbia, Slovakia, Slovenia, Turkey. The East (15 countries): Armenia, Azerbaijan, Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Republic of Moldova, Russian Federation, Tajikistan, Turkmenistan, Ukraine, Uzbekistan.
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